SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
April
6, 2005
Date
of Report
(Date
of earliest event reported)
RITA
Medical Systems, Inc.
(Exact
name of registrant as specified in its charter)
Delaware
(State
or other jurisdiction of incorporation)
000-30959 |
94-3199149 |
|
(Commission
File Number) |
(I.R.S.
Employer Identification No.) |
967
N. Shoreline Blvd.
Mountain
View, CA 94043
(Address
of principal executive offices, with zip code)
(650)
314-3400
(Registrant's
telephone number, including area code)
Item
8.01. Other Events and Required FD Disclosure.
On April
4, 2005, RITA Medical Systems, Inc. (Nasdaq: RITA) announced that radiofrequency
ablation (RFA) was featured in more than 15 clinical papers presented at the
Society of Interventional Radiology 2005 Annual Meeting, held in New
Orleans March 31 through April 5. In addition to podium presentations,
poster sessions, educational workshops and other clinical presentations
involving RFA, conference organizers presented clinical data from studies using
RITA RFA technology for treating pain in patients whose liver cancer has
metastasized to the bone, and in lung cancer patients with unresectable tumors.
A copy of RITA’s press release announcing this introduction is attached as
Exhibit 99.1 hereto and incorporated by reference herein.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
|
|
| |
RITA Medical
Systems, Inc. |
|
|
|
| Date: April 7, 2005 |
By: |
/s/ Donald Stewart |
| |
Donald
Stewart, Chief Financial Officer and
Vice
President Finance and Administration |
| |
|
RITA
MEDICAL SYSTEMS, INC.
INDEX
TO EXHIBITS
Exhibit
Number |
Description |
| |
|
|
99.1 |
Press
Release of RITA Medical Systems, Inc. dated April 6,
2005. |